Myomo, Inc. Announces Participation in A.G.P.’s Virtual MedTech Summer Conference on July 29, 2021

Rhea-AI Summary

Myomo, Inc. (NYSE American: MYO) has announced its participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021. This virtual event will allow investors to engage in one-on-one meetings with Myomo's management team. Myomo specializes in wearable medical robotics, particularly the MyoPro product line, which aids individuals with neurological disorders and upper-limb paralysis. The MyoPro device is unique for its ability to restore arm function using non-invasive EMG sensors, enabling users to perform daily activities and live independently.

Positive

• Participation in A.G.P.'s Virtual MedTech Summer Conference may increase investor engagement.
• Myomo's MyoPro product is the only marketed device that restores arm function through EMG sensors.

Negative

• None.

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021.

The event will consist of one-on-one virtual investor meetings. Investors participating in the virtual conference who are interested in meeting with members of Myomo’s management team should contact their A.G.P. representative.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210723005404/en/

FAQ

What is Myomo, Inc. known for?

Myomo, Inc. is known for its wearable medical robotics that enhance arm and hand function for individuals with neurological disorders and upper-limb paralysis.

When will Myomo participate in the MedTech Summer Conference?

Myomo will participate in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021.

What is the MyoPro product line?

The MyoPro product line consists of powered upper limb orthoses designed to support and restore function to weakened or paralyzed arms.

How does the MyoPro device work?

The MyoPro device uses non-invasive EMG sensors that detect the patient's own muscle signals to restore arm function.